TrialBMC medicine2024

Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study.

Ji-Youn Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.